News

NIH cancels research grant for disease that affects mostly Black patients, citing DEI, doctor says
Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.
Beam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease Trial
Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
IEEE5d
Segmentation of White Blood Cell, Nucleus and Cytoplasm in Digital Haematology Microscope Images: A Review–Challenges, Current and Future Potential Techniques - IEEE Xplore
Segmentation of white blood cells in digital haematology microscope images represents one of the major tools in the diagnosis and evaluation of blood disorders. Pathological examinations are being the ...